Supply Chain
New research from Advisory Board, conducted in partnership with Staples Business, reveals how 102 health system supply chain and executive…
Reps. Elijah Cummings, D-Md., and Peter Welch, D-Vt., on Wednesday met with President Donald Trump to discuss strategies for lowering drug costs, reports Kaiser Health News.
The ACA replacement plan House Republicans released Monday would permanently repeal the medical device tax, reports MinnPost.
While drug price transparency legislation may not actually lower drug prices, it could provide valuable insight into whether a drug's price is reasonable, reports The Hill.
President Donald Trump on Tuesday tweeted about his yet-to-be-revealed strategy for lowering drug prices, which caused pharmaceutical stocks to fall, reports Bloomberg.
ABBOTT PARK, Ill., March 8, 2017 /PRNewswire/ -- New study results published in Human Reproduction could pave the way for an additional treatment option for the estimated 1.5 million women worldwide who undergo in vitro fertilization (IVF) treatment each year.
Prescriptions for alternative versions of Mylan's EpiPen device have almost quadrupled in 2017, according to a new report from athenaInsight.
Neil Gorsuch, President Donald Trump's Supreme Court nominee, believes federal law should protect device companies from lawsuits filed by patients injured by their devices, reports StarTribune.
The amount of states involved in a price-fixing lawsuit against six generic drugmakers has doubled, reports Myrtle Beach Online.
The pharmaceutical industry spent 9 percent more on direct-to-consumer ads in 2016 than in the year prior, with total spending reaching $5.6 billion, according to a Medical Marketing & Media report.
A new study published in Health Affairs disproves the drug industry's most popular response to criticism over the high cost of medications in America: Drug prices support innovation for new medicines.